Over the past six months, eHealth’s shares (currently trading at $5.33) have posted a disappointing 12.5% loss, well below the S&P 500’s 24.4% gain. This might have investors contemplating their next move.

Is now the time to buy eHealth, or should you be careful about including it in your portfolio? Dive into our full research report to see our analyst team’s opinion, it’s free for active Edge members.

Why Is eHealth Not Exciting?

Even with the cheaper entry price, we don't have much confidence in eHealth. Here are three reasons there are better opportunities than EHTH and a stock we'd rather own.

1. Declining Estimated Membership Reflect Product Weakness

As an online marketplace, eHealth generates revenue growth by increasing both the number of users on its platform and the average order size in dollars.

eHealth struggled with new customer acquisition over the last two years as its estimated membership have declined by 2.2% annually to 1.15 million in the latest quarter. This performance isn't ideal because internet usage is secular, meaning there are typically unaddressed market opportunities. If eHealth wants to accelerate growth, it likely needs to enhance the appeal of its current offerings or innovate with new products.

2. Revenue Projections Show Stormy Skies Ahead

Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite.

Over the next 12 months, sell-side analysts expect eHealth’s revenue to drop by 2.5%, a decrease from This projection is underwhelming and implies its products and services will see some demand headwinds.

3. Cash Burn Ignites Concerns

Free cash flow isn't a prominently featured metric in company financials and earnings releases, but we think it's telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king.

eHealth’s demanding reinvestments have consumed many resources over the last two years, contributing to an average free cash flow margin of negative 6.8%. This means it lit $6.76 of cash on fire for every $100 in revenue. This is a stark contrast from its EBITDA margin, and its investments (i.e., stocking inventory, building new facilities) are the primary culprit.

Final Judgment

eHealth isn’t a terrible business, but it doesn’t pass our bar. After the recent drawdown, the stock trades at 4× forward EV/EBITDA (or $5.33 per share). While this valuation is optically cheap, the potential downside is big given its shaky fundamentals. We're pretty confident there are more exciting stocks to buy at the moment. We’d recommend looking at an all-weather company that owns household favorite Taco Bell.

Stocks We Like More Than eHealth

Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.

The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.